Andrew Toy

Chief Executive Officer at @CloverHealth.

Primary platform is LinkedIn. Follow me there!

[Andrew Toy @andrewtoy]

Here’s @vivekgaripalli on @CloverHealth’s role in the future of healthcare 🍀

[Vivek Garipalli @VivekGaripalli]

I’m beyond excited for @CloverHealth's future, especially with this being the first week with @andrewtoy as CEO. I look forward to everyone seeing what I and others close to Andrew know he’s capable of — building a huge success while improving every life: https://t.co/ejQkpwu05y

[Andrew Toy @andrewtoy]

See my original post on LinkedIn: https://t.co/lohUOVDP5X #Healthcare #Personalization #Software

[Andrew Toy @andrewtoy]

That’s where #CloverAssistant comes in – delivering personalized, data-driven care recommendations that can scale at the speed of software – allowing every person to be treated like an individual instead of the average of a whole. @CloverHealth $CLOV

[Andrew Toy @andrewtoy]

It’s mind blowing that doctors are blanket-prescribing drugs just to get higher scores on population health metrics, but unfortunately they are rewarded for box-checking at the cost of customized targeted care

[Andrew Toy @andrewtoy]

What’s even crazier is that the doctor’s unnamed health system will receive higher star ratings (which leads to increased revenue, prestige and enrollment) based on doing the WRONG thing for my friend

[Andrew Toy @andrewtoy]

To maintain his quality scores, he NEEDS her on these drugs, despite the fact that they are not necessarily medically appropriate for her

[Andrew Toy @andrewtoy]

Why is he still pushing prescriptions? Because on average this is the right decision for someone with her disease burden, and for his population health quality metrics, that trumps her individual needs

[Andrew Toy @andrewtoy]

However, her doctor (at a very popular verticalized healthcare system in California that will remain unnamed) is constantly pressuring her to take metformin and a statin, even though in her case, her chronic disease is being managed through lifestyle changes

[Andrew Toy @andrewtoy]

A friend of mine, a black woman, has Type II diabetes. She’s very responsible when it comes to managing her condition and has improved her diet to control her A1C

[Andrew Toy @andrewtoy]

Here’s an example of where #ValueBasedCare based on population health breaks down...

[Andrew Toy @andrewtoy]

That obviously won’t work. Every person has unique needs, which require personalized attention and care. While it seems like a no-brainer, the challenge here is that this level of care is very hard to scale. Hence why the industry has settled for population health

[Andrew Toy @andrewtoy]

I like the spirit of #PopulationHealth but I hate the way it’s worded. Why? It sounds like it endorses managing health at the “population” level, aka treating each individual like the average of the whole

[Andrew Toy @andrewtoy]

Helping more PCPs participate in #ValueBasedCare (aka SUPPORTING the ones that are already HERE and caring for patients) will help create equity in the system. Period. That’s what we’re working to do at @Clover Health $CLOV https://t.co/kXmNKx0enf

[Andrew Toy @andrewtoy]

Everyone knows about the mounting #DoctorShortage in the US. It’s been in the headlines for years. But there’s another layer to the problem - one of the biggest in #healthcare today - that no one’s talking about…

[Andrew Toy @andrewtoy]

Open, inclusive networks are essential for health equity. So I continue to ask myself…why are we okay with letting narrow networks dominate the insurance landscape?